18F-MNI-1054

N/A

Report date: 2025/09/24 17:41:46

Base Information

Drug Name18F-MNI-1054
Drug Alias Name18F-MNI-1054[18F]MNI-1054
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionLysine-specific histone demethylase 1 modulatorsPositron-emission tomography enhancers
TargetsLysine-specific histone demethylase 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInvicro Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharmaceutical Co LtdInvicro Llc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A